• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2007

View Archived Issues

VioQuest cancer agents progress through early studies

Read More

Docetaxel/telatinib combination shows promise in cancer patients

Read More

Lorus reports first quarter results for fiscal 2008

Read More

HNE scavengers may have potential in AD

Read More

Shire licenses Amigal, Plicera and AT-2220 from Amicus for markets outside of the U.S.

Read More

Preliminary study results show FG-4592 well tolerated in CKD anemia

Read More

Ferric carboxymaltose injection shows promise in non-dialysis-dependent CKD anemia

Read More

Recent developments for Pharmaxis' Bronchitol and Aridol

Read More

Post hoc analyses of IDEAL, SPARCL studies show additional benefits of atorvastatin

Read More

Phase I study results for ARC-1779 in healthy volunteers available

Read More

LY-518674 increases apo A-I production but not HDL cholesterol in metabolic syndrome patients

Read More

Phoqus presents update on clinical trial program for Chronocort

Read More

TB Alliance conducts clinical trials on moxifloxacin and PA-824 for TB

Read More

Santhera initiates FJORD clinical trial of JP-1730 for dyskinesia in Parkinson's disease

Read More

Pharmexa reports positive preliminary results from the HVTN 064 phase I trial of EP-1043

Read More

Antisense initiates collaborative research program to examine ATL-1101 for prostate cancer

Read More

Vivus initiates EQUIP phase III trial of Qnexa in morbidly obese patients

Read More

Seattle Genetics initiates phase IIb clinical trial of SGN-33 for acute myeloid leukemia

Read More

Expression Genetics receives grant from the National Cancer Institute to develop EGEN-001

Read More

Elite concludes special protocol assessment with FDA for phase III trial of ELI-216

Read More

KeyNeurotek initiates phase I study of cannabinoid receptor agonist KN-38-7271 for stroke

Read More

Santhera presents an update on its clinical development portfolio

Read More

FDA accepts Akesis' IND application for phase IIa study of AKP-020 for type 2 diabetes

Read More

AtheroGenics discontinuing 300 mg dose of AGI-1067 in ANDES trial

Read More

FDA requests additional data for Synvisc-One marketing application

Read More

Short-acting sedative-hypnotic presented at Neuroscience meeting

Read More

First marketing authorization application submitted for Advexin

Read More

Na+ and Ca2+ channel-blocking antiepileptic with a promising pharmacological profile

Read More

Recent Tibotec and Pfizer patents report new therapeutic agents for HIV infection

Read More

Novel agents for cardiovascular disorders disclosed in recent patents

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe